$ME->Wakeup('2021-02-15 00:00:00');
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Idiocracy . . .
There's a person/group basically threatening legal action against RLF AG. He/they sent what amounts to be a complaint to RLF AG, my company, your company, OUR company. This is the company we are part owners in. We just spent money on lawyers to look over his complaint and our CEO's response as well. This could lead to minimal future communications, interviews and preliminary data reads. At the very least, ANYTHING will be heavily scrutinized now.
Not only is it counterproductive to the authors stated goal & "concern"...IMO, THIS SHORT SIGHTED ACTION HAMPERS THE TIMING OF ENDING A GLOBAL PANDEMIC!
If you know him or have taken part of this, be sure to tell your grandkids you were not at all happy during this time and took part in threatening the company that brought an end to the great COVID-19 pandemic by bringing Aviptadil to the world; you did your part in slowing things down further. That will be your story, forever engraved in your history.
Here is the complaint and response:
https://imgur.com/a/vUCAOEK
SMH,
JB
THE MOST EXCITING RESULTS OF ANY COMPANY RELEASED
72% of patients too sick for trial survived and that's all I see is petty ill informed RLFTF traders "I thought they said this, I'm not happy"
Part of me feels they are not even deserving of the financial windfall and the blessing to human kind RLF-100 will bring. They just got lucky. They fail to see their own public actions drive others away by stoking fear and uncertainty. I'm not saying they're stupid BUT they definitely didn't get as lucky when it comes to intelligence imo.
Best,
JB
Safe & Effective treatment is what is needed. Once people realize vaccines are not the answer and we somehow get through this winter -- Therapeutics will sky rocket. Just have to hold and be patient, share prices will only keep increasing exponentially IMO. Big things are coming, buckle up
Best,
JB
Big time movement today!!! Congrats Revive investors your ship is coming in!!!!
GLTA
#INTERIMTRIALDATA
"Of the 90 patients who have so far reached 28 days of follow-up, 72% survived to day 28"
<RICK FLAIR> WOOOOOOOOOOOOOO!
NEURORX AND RELIEF ANNOUNCE INITIAL SUCCESSFUL RESULTS FROM EXPANDED ACCESS USE OF RLF-100™ (AVIPTADIL) IN PATIENTS WITH CRITICAL COVID-19 AND SEVERE COMORBIDITY: 72% SURVIVAL SEEN IN ICU PATIENTS
https://relieftherapeutics.com/newsblog/neurorx-and-relief-announce-initial-successful-results-from-expanded-access-use-of-rlf-100-aviptadil-in-patients-with-critical-covid-19-and-severe-comorbidity-72-survival-seen-in-icu-patients
They clearly state in the Inhaled trial Nebulized RLF-100
"In this study, patients patients with moderate and severe COVID-19 by FDA definition who have not developed respiratory failure be treated with nebulized RLF-100 100 µg 3x daily plus Standard of Care vs. placebo + Standard of Care using an FDA 501(k) cleared mesh nebulizer."
https://clinicaltrials.gov/ct2/show/NCT04360096
I AGAIN fail to see your point(Maybe I am too generous in thinking there is one) ...
Sheesh,
JB
Lets start with AVIPTADILSAVESLIVES
I actually KNOW many believe this and the empirical evidence thus far supports this statement. Rumor has it there is even a dot com associated with this :)
In regards to available "doses": Peptide synthesis is not difficult and RLF-100 "doses" can be churned out rather quickly. Now if you consider a full course is 3 doses --- that gets you to about 100k doses. If you listen to this one news report where the reporter is talking about the inhaler trials etc then sure stick with your 30k. Many however am more savvy and realize official statements from the company, if proven to be untrue o misleading, can be a solid basis for class action suits. The facts are that the everything hangs upon the trial completion and pending approval for severe. The company has stated numerous times that this is their focus.
As far as fully funded, the company never said that either:
"Relief believes that with the conclusion of this raise, its capital resources will be sufficient to support its planned operations through 2022, without taking into account potential revenues generated from sales of RLF-100"
https://www.relieftherapeutics.com/newsblog/relief-announces-capital-increase-from-its-final-tranche-of-the-share-subscription-facility-with-gem
Now consider that the possibly that RLFTF might want to do a reverse merger for example, need some shares and capital to do that. They must have their eye on something unbeknownst to us at this point in time
Then dilution, warrant execution is not "dilution" per se, those RLF shares issued to GEM where always there and the public float has NOT changed at all.
"How many investors have they presented to?" Well that's easy, 1... RLF AG presented at a Deutche Bank conference. All the other mentioned were done by NeuroRX who is our partner and leading the US Trials.
I also agree that it appears fair weather RLFTF "traders" are "los(ing) their sh**" BUT can assure you RLFTF investors are extremely confident as a steady stream of nothing but positive news is released with exponential frequency. Upon release of the empirical data, I assume those very same RLFTF "traders" will be letting everyone know how they have always been in this from the beginning and helped see it get to the public faster but the internet never forgets.
Best,
JB
CSLI CEO NEW POST
https://www.facebook.com/photo/?fbid=1585555058311947&set=a.107260216141446
Clearly sets 12/08/20 as a big day
FINALLY LONG AWAITED NEWS FROM CSLI CEO!!!
You are right way past due WV, The CEO has now indicated the strategic direction and company priorities!
https://www.facebook.com/photo/?fbid=1585555058311947&set=a.107260216141446
12/08/20 Seems to be the big day!!
/s
There are at least 2 several day long FDA events during that timeframe
As weird as it may sound, it would be good for me if many others feel like you do. I have enough dry powder to cover entire markets caps for many OTCs BUT if I see an opportunity to get myself to 2.999% ownership on another massive RLFTF dip, I just may.
Might I suggest waiting to see what transpires between now and then... it would be in your own best interests.
Best,
JB
I cannot help anyone read RLF tea leaves bit can assure you I do more than just that.
You waited this long right? You have been begging for a date right? Rest assured that when your vote is cast you will be thinking "Heh, they only wanted a 50% raise... I would have given them 150%% raise"
Just hold and let the timeline unfold
PS Anyone know of anything of interest occurring between 12/4-12/17... I do!
Best,
JB
Great post but that Share Registration site is incorrect and BS. That information simply is not true that they have no idea unless we register with Thomas
Good News All, Exciting New PR
It looks like a Reverse Merger or an acquisition is in our future. We also have an timeline for something "extraordinary".
https://relieftherapeutics.com/newsblog/relief-announces-notice-of-extraordinary-general-meeting-of-relief-therapeutics-holding-ag
Let me know if you do not understand the significance of this.
Best,
JB
They said they would be more than willing to discuss EAP with other countries, even encouraged it. Many have said they even have begun talks with other countries. I have several links even.
What you are referring to clearly said "trials" because conducting trials is extremely burdensome on a company's resources (bandwidth). They are focused on their ongoing trial in the country with the most cases, the most deaths and the most strict regulatory approval process. They are more than willing to get the drug to other countries though, it would be through EAP much like any hospital in the USA can get this drug while awaiting the trial results and FFA approval
And a better anology would be you were already "testing" carrying 3 children out of the bus's path and couldnt "test" the 1 to see if carrying truly worked -- if he wanted to be carried as a life saving measure, you still would carry him though
Best,
JB
The original poster did not include the rest of the information, they clearly are open to working with other countries. Many even have said they already are.
====
We are painfully aware of the global nature of the COVID-19 pandemic.
We are fielding multiple requests from representatives of health ministries, who would like to access RLF-100 for their countries.
At this point in time, NeuroRx does not have the bandwidth to enter into the traditional drug approval process outside the United States. We are, however, prepared to partner with emergency use programs with Health Ministry approval.
====
https://www.neurorxpharma.com/our-services/non-us-country-rep/
Best,
JB
No one ever announced he accepted, just that he was voted. He is NOT on the board currently due to a conflict it causes. Again, none ever told you he was. Happy? Get over the tin foil hat conspiracy. We are on the same team.
I know you are invested, do you think fear mongering helps your investment? Does it help get RLF-100 to people sooner? When you don't shout and act like RLFTF is your beau instead, some of your posts could be very helpful. You could even correll some people into investing into RLFTF!!!
Best,
JB
You forgot the best part, when they find themselves not holding shares because they were playing the ticker and us "investors" get to say to them: "You get nothing, You lose! GOOD DAY SIR!!"
Cheers,
JB
So the goal is showing statistical significance.
They added in a few extra to be sure but all along the DMC has indicated the trial should continue as it seemed this could be achieved and there was no indication of futility. They even increased the size of the DMC, they voted unanimously to continue. We need 15 but will get more. A therapeutic that has proven safety and efficacy for an global pandemic that has crushed every nation on earth as well as a whole host of other respiratory ailments is one of the most monumental medical discoveries ever. The facts of the matter are that while most think the common cold is the Rhinovirus but many estimate 20% are caused by a coronavirus. So you probably have had several variants, especially whatever that was after that one spring break rave in the 90s. They are very common and have many variants in many species. Many even look like they have the potential to cross species but fortunately have not (at least yet). Newly introduced pathogens into a species can be decimating to the point of extinction. They are not easy to fight off by acquired immunity since they often mutate. That's the fatal flaw in the pursuit of the vaccine. Sometimes no matter how much time, effort and money you throw at something it remains unattainable. It appears many have dug in so deep they now have confirmation bias in that it is the correct approach.
We are in the middle of a historic medical achievement, every person here plays a part in it and will have a story to tell what it was like when we invested in this fancy new drug that is like penncillian and lipitor combined. It even had a code name, RLF-100...
Best,
JB
The Company Working to Prevent Respiratory Failure in COVID-19 Patients
https://www.phillymag.com/healthcare-news/2020/11/18/neurorx-respiratory-failure-covid-19/
Dr. Johnathan Javitt - Aviptadil (RLF-100) - World Leading Hospitals 11/18/2020
SAFETY & EFFICACY ARE WHAT MATTERS
Once the shift towards therapeutics being the answer is fully recognized, the promising ones will skyrocket. This has not happened yet but will soon. Big Pharma is eyeing up acquisitions already, ones with proven safety and efficacy will rise to the top.
RVVTF has this, just like the other company RLFTF. Both actually have a 30 year track record as well. I think it is entirely possible they could be used in conjunction at some point. Look at the MOA of bucillamine and do your DD.
That being said, only "traders" are releasing shares. As an investor, I will hang onto my RVVTF position as I see good things coming.
I pick winners...
Best,
JB
Today's. RLFTF breakout will be nice, but nothing compared to what future catalysts will bring. Just hold tight and enjoy the ride... this is still just the beginning
Best,
JB
I honestly think both of the 2 companies you mentioned are on similar paths with their drugs and they could be used in conjunction possibly. I feel I have stepped into an alternate universe having to write this to you as well... smh
BP is HUNTING For Proven Safety & Efficacy
I think the study completion is crucial, it will be full soon. So yes, I do not think an EUA would be granted prior. Full approval is also a possibility as we are the only ones doing it by the books
Best,
JB
RVVTF is going to pop IMO, I almost feel bad for whoever's shares I have received. The reality is that Bucillamine appears to be able to save lives and every BP is now eyeing therapeutics. Ones with proven safety & efficacy are hard to come by...BUCKLE UP!
FYI I bought some more RVVTF today
I have held this for a while despite what many have thought, 0.20+ breakthrough seems likely IMO
A valid and complete scientific FDA study is crucial for a drugs apprival.We need 15 more patients as they know the sample size etc and have been ok with... it should be followed through to completion
Best,
JB
Wow... I did not see that coming. Uhm well, I guess I have to say nice post Vanilla!
Best,
JB
"On 28 August 2006, orphan designation (EU/3/06/395) was granted by the European Commission to mondoBIOTECH Laboratories, Lichtenstein, for Aviptadil for the treatment of acute lung injury."
https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu306395
BTW have you seen the xrays from the latest PR ... They are not subjective and it is blatantly obvious at what RLF-100(Aviptadil) does. There is NO OTHER THERAPY that has that kind of results otherwise we would have seen THEIR images.
It is coming...
Best,
JB
Exactly, a built in safety valve to prevent HTO
It has all been laid out in the FS for all to see
Best,
JB
NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure
- Observations of rapid recovery noted on chest x-ray and no drug-related Serious Adverse Events reported
RADNOR, Pa. and GENEVA, Nov. 13, 2020 /PRNewswire/ -- NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF, OTCBB:RLFTF) ("Relief") announced that as of today, 150 patients (out of a targeted enrollment of 165) have been enrolled in the ongoing phase 2b/3 trial of RLF-100™ (aviptadil) for treating respiratory failure in patients with Critical COVID-19. Respiratory failure is defined, according to FDA guidance, as the need for intensive care with mechanical ventilation, non-invasive ventilation, or high-flow nasal oxygen in order to sustain adequate levels of blood oxygen. So far, no drug-related Serious Adverse Events have been reported.
https://finance.yahoo.com/news/neurorx-relief-therapeutics-announce-enrollment-100000411.html
Great article, significant movement on Monday is likely. Anyone know ANY OTHER COVID therapeutic showing results with diagnostic imaging!!!
https://media.zenfs.com/en/prnewswire.com/13e4c0eacb2ca75d4a328ec4c7003f48
#REALFKNDEAL
Best,
JB
Its been a link on the top of this page since I redid it
https://www.google.com/search?q=%22aviptadil%22+OR+%22rlftf%22+OR+%22RLF-100%22+OR+%22relief+therapeutics%22&rlz=1C1CHBF_enUS704US711&tbm=nws&sxsrf=ALeKk03kWIZnl99iKOnxBgahQXLi7lu3VQ:1598480689226&source=lnt&tbs=qdr:h&sa=X&ved=0ahUKEwiq9aTN9LnrAhXCnOAKHb9BBBMQpwUIJQ&biw=1320&bih=533&dpr=1
Prolly to say trial failed....Its not looking very good for us RVVTF folks...Sad :(
I agree it’s a good drug, I’ve been hearing they are waiting on results next month from the phase 3 Covid study on RLFTF. Either way I believe we are golden :)
RELIEF, WITH PARTNER NEURORX, ANNOUNCES ENROLLMENT OF 150 PATIENTS IN PHASE 2B/3 TRIAL OF RLF-100™ FOR CRITICAL COVID-19 WITH RESPIRATORY FAILURE
13 November 2020
https://relieftherapeutics.com/newsblog/123-relief-therapeutics-and-neurorx-announce-continuation-of-rlf-100-trial-for-treatment-of-covid-19-respiratory-failure-trial-is-on-track-to-complete-enrollment-in-2022